Sanjivani Paranteral reports 58% growth in Q4 FY24 revenue at Rs 128.64 million
Sanjivani Paranteral Ltd (BSE: 531569), a renowned pharmaceutical company based in Mumbai with manufacturing facilities in Navi Mumbai and Dehradun, has announced impressive financial results for the fourth quarter of FY24, showcasing significant growth and strategic expansions. Financial Performance Highlights: In Q4 FY24, Sanjivani Paranteral reported a substantial increase in revenue, which grew 58.38% year-over-year […]